Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Langmann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Retina (Philadelphia, Pa.)|August 10, 2004
Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgeryBeate Schatz, Yosuf El-Shabrawi, Anton Haas, et al.
Lasers in Surgery and Medicine|January 22, 2005
Evaluation of a KTP (potassium-titanyl-phosphate) 532 nm laser for endovaporization of choroidal melanomasDietmar Mattes, Eva-Margarete Reich, Klaus Muellner, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in AustriaPetra Sovinz, Christian Urban, Herwig Lackner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 27, 2007
Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106Georg Mossböck, Thomas Rauscher, Peter Winkler, et al.
Journal of Neurosurgery|January 1, 2003
High-compared with low-dose radiosurgery for uveal melanomasGerald Langmann, Gerhard Pendl, Klaus Müllner, et al.
Plos One|September 1, 2017
Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomasLisa Tarmann, Werner Wackernagel, Domagoj Ivastinovic, et al.
The British Journal of Ophthalmology|May 17, 2015
Ruthenium-106 plaque brachytherapy for uveal melanomaLisa Tarmann, Werner Wackernagel, Alexander Avian, et al.
Wiener Klinische Wochenschrift|August 2, 2005
Lymph node metastases arising from uveal melanomaNavid Ardjomand, Peter Komericki, Gerald Langmann, et al.
Melanoma Research|November 30, 2005
Five-year results of prognostic value of tyrosinase in peripheral blood of uveal melanoma patientsIngrid Boldin, Gerald Langmann, Eva Richtig, et al.
The British Journal of Ophthalmology|November 9, 2012
Visual acuity after Gamma-Knife radiosurgery of choroidal melanomasWerner Wackernagel, Etienne Holl, Lisa Tarmann, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Retina (Philadelphia, Pa.)|August 10, 2004
Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgeryBeate Schatz, Yosuf El-Shabrawi, Anton Haas, et al.
Lasers in Surgery and Medicine|January 22, 2005
Evaluation of a KTP (potassium-titanyl-phosphate) 532 nm laser for endovaporization of choroidal melanomasDietmar Mattes, Eva-Margarete Reich, Klaus Muellner, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in AustriaPetra Sovinz, Christian Urban, Herwig Lackner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 27, 2007
Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106Georg Mossböck, Thomas Rauscher, Peter Winkler, et al.
Journal of Neurosurgery|January 1, 2003
High-compared with low-dose radiosurgery for uveal melanomasGerald Langmann, Gerhard Pendl, Klaus Müllner, et al.
Plos One|September 1, 2017
Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomasLisa Tarmann, Werner Wackernagel, Domagoj Ivastinovic, et al.
The British Journal of Ophthalmology|May 17, 2015
Ruthenium-106 plaque brachytherapy for uveal melanomaLisa Tarmann, Werner Wackernagel, Alexander Avian, et al.
Wiener Klinische Wochenschrift|August 2, 2005
Lymph node metastases arising from uveal melanomaNavid Ardjomand, Peter Komericki, Gerald Langmann, et al.
Melanoma Research|November 30, 2005
Five-year results of prognostic value of tyrosinase in peripheral blood of uveal melanoma patientsIngrid Boldin, Gerald Langmann, Eva Richtig, et al.
The British Journal of Ophthalmology|November 9, 2012
Visual acuity after Gamma-Knife radiosurgery of choroidal melanomasWerner Wackernagel, Etienne Holl, Lisa Tarmann, et al.
Pageof 2